A widely prescribed anti-seizure medicine slowed the growth of one of childhood's deadliest brain cancers in laboratory research, Stanford Medicine scientists reported.
The drug, levetiracetam, is often sold under the brand name Keppra. Medical records also showed that children with diffuse midline gliomas who received it lived longer on average than those who did not, according to Medical Xpress.
